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Abstract: Opportunistic mycoses increase the morbidity and mortality of immuno-compromised 
patients. Five Candida species have been shown to be responsible for 97% of worldwide cases 
of invasive candidiasis. Resistance of C. glabrata and C. krusei to azoles has been reported, 
and new, improved antifungal agents are needed. The current study was designed to evaluatethe 
activity of various polyphenolic compounds against Candida species. Antifungal activity was 
evaluated following the M27-A3 protocol of the Clinical and Laboratory Standards Institute, 
and antioxidant activity was determined using the DPPH assay. Myricetin and baicalein 
inhibited the growth of all species tested. This effect was strongest against C. glabrata, for 
which the minimum inhibitory concentration (MIC) value was lower than that of fluconazole. 
The MIC values against C. glabrata for myricitrin, luteolin, quercetin, 3-hydroxyflavone, 
and fisetin were similar to that of fluconazole. The antioxidant activity of all compounds was 
confirmed, and polyphenolic compounds with antioxidant activity had the greatest activity 
against C. glabrata. The structure and position of their hydroxyl groups appear to influence 
their activity against C. glabrata. 
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1. Introduction 
The World Health Organization reported in 2004 that infectious diseases were among the top 10 causes 
of death in the general population and among the top five causes in children younger than 5 years [1]. 
However, few drugs are available, and most of them are associated with toxicity [2]. 
Candida species comprise one of the four main types of organisms that can be isolated from blood 
cultures of hospitalized patients and are the most important cause of opportunistic fungal infection 
worldwide [3]. The Candida genus comprises about 154 species, although 97% of invasive candidiasis 
is attributed mainly to five species: C. albicans (42.1%), C. glabrata (26.7%), C. parapsilosis (15.9%), 
C. tropicalis (8.7%), and C. krusei (3.4%) [3]. In Mexico, C. glabrata is the predominant species that 
causes vaginal mycosis [4]. The main challenge to the future development of prophylactic and therapeutic 
strategies is the resistance of species other than C. albicans to the available antifungal drugs. Resistance to 
azoles is a potential problem for treating infections caused by C. glabrata, C. krusei, and other less common 
species [5]. 
Considering the medical importance of the Candida species, we assessed the antifungal activity of a 
large number of extracts and compounds isolated from plants. We used clinical isolates of the major species 
that cause candidiasis as a study model. Recently, we reported on the antimicrobial activity of extracts 
from 17 plants that grow wild in the northeastern region of Mexico [6]. All plant extracts showed activity 
against at least one isolate of Candida species, of which C. glabrata was the most sensitive. In addition, 
>80% of extracts with activity against C. glabrata clearly showed high antioxidant activity. These plant 
extracts also had a high level of polyphenolic compounds, especially flavonoids. 
Polyphenolic compounds are secondary metabolites that are widely distributed in the plant kingdom 
and are often consumed through beverages and foods made from the plants that contain them. Most 
polyphenols in plants are flavonoids, which contribute to the defense against plant pathogens and the 
response to changing environmental conditions [7]. The antimicrobial activity of flavonoids and their 
glycosylated derivatives has been investigated widely, and associations between their antimicrobial and 
antioxidant activities have been suggested [8]. However, little has been reported about the activity of certain 
flavonoids against strains of C. glabrata. We evaluated whether 18 polyphenolic compounds exerted 
inhibitory effects on the growth of C. albicans, C. parapsilosis, C. tropicalis, C. krusei, and C. glabrata. 
2. Results and Discussion 
Both baicalein and myricetin inhibited the growth of all species of yeast used in our study. Baicalein 
showed the greatest activity, although both were less active than the positive control, fluconazole (Table 1). 
The exception was C. glabrata, which was inhibited to a greater degree by these two compounds than 
by the control. 
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Table 1. MIC values of flavonoids on isolates of Candida species. 
 Candida Isolate 
Flavonoid # 
C. 
tropicalis 
166 
C. 
krusei 
168 
C. 
parapsilosis 
96 
C. 
albicans 
498 
C. 
albicans 
501 
C. 
albicans 
53 
C. albicans 
ATCC 
10231 
C. 
glabrata 
510 
C. 
glabrata 
493 
C. 
glabrata 
482 
C. 
glabrata 
531 
C. 
glabrata 
587 
C. 
glabrata 
507 
Baicalein 10.4 21 5.2 10.4 10.4 10.4 10.4 1.9 1.9 1.9 1.9 1.9 1.9 
Myricetin 64 64 16 64 32 16 ND 3.9 3.9 3.9 3.9 3.9 3.9 
Myricitrin >83 >83 >83 >83 >83 >83 >83 3.9 3.9 3.9 3.9 7.8 7.8 
Luteolin >83 >83 >83 >83 >83 >83 >83 7.8 3.9 3.9 7.8 7.8 7.8 
Quercetin >83 >83 >83 >83 >83 >83 >83 15.6 15.6 7.8 7.8 7.8 7.8 
3-Hydroxyflavone >83 >83 >83 >83 >83 >83 >83 3.9 7.8 15.6 15.6 15.6 3.9 
Fisetin >83 >83 >83 >83 >83 >83 >83 7.8 7.8 7.8 7.8 15.6 15.6 
Quercitrin >83 >83 >83 >83 >83 >83 >83 62.5 31.2 7.8 7.8 7.8 7.8 
Kaempferol >83 >83 >83 >83 >83 >83 >83 31.2 31.2 31.2 31.2 31.2 31.2 
Galangin >83 >83 >83 >83 >83 >83 >83 31.2 31.2 15.6 31.2 31.2 62.5 
Flavone >83 >83 >83 >83 >83 >83 >83 62.5 62.5 62.5 62.5 62.5 62.5 
Fluconazole 1.9 3.9 0.9 0.9 0.5 3.9 0.5 1.9 3.9 3.9 31.2 7.8 3.9 
# MIC values for each flavonoid are listed as µg/mL; ND, not determined. 5-hydroxyflavone, 6-hydroxyflavone, 7-hydroxyflavone, chrysin, apigenin, naringenin, and 
hesperetin showed no effect on the growth of Candida species at the highest concentration used (83 µg/mL). 
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Eleven compounds showed growth-inhibiting activity against the six clinical isolates of C. glabrata. 
Baicalein and myricetin showed activity against all clinical isolates of C. glabrata, and this activity was 
equivalent to or greater than that of fluconazole (Table 1). Myricitrin, luteolin, quercetin, 3-hydroxyflavone, 
and fisetin caused strong inhibition of the growth of C. glabrata and had minimum inhibitory concentration 
(MIC) values similar to those of the positive control. Quercitrin, kaempferol, galangin, and flavone also 
showed inhibitory activity against C. glabrata growth, although their MIC values were higher than those 
of the positive control. Clinical isolate 531, which was resistant to fluconazole, was susceptible to at 
least seven of the flavonoids studied. 
Eight of the 18 compounds tested showed good antioxidant activity; their median effective concentration 
values (EC50) were <20 µM (Table 2). 
Table 2. EC50 for reduction of 2,2-diphenyl,1-picrylhydrazyl (DPPH). 
Flavonoid MW EC50 (µM) Previously Reported (µM) Reference 
Luteolin 286.2 3.46 
22.8 [9] 
1.8 [10] 
Fisetin 286.2 5.34 
11.8 [11] 
1.1 [10] 
Myricetin 318.2 9.1 
12.3 [11] 
1.6 [10] 
Quercetin 302.2 10.6 
2.2 [11] 
8.1 [10] 
9.7 [12] 
Kaempferol 286.2 11.6 
25.7 [11] 
7.2 [10] 
Baicalein 270.2 17.6 5.1 [10] 
Myricitrin 464.4 11.6 12.7 [13] 
Quercitrin 448.4 12.5 11 [12] 
Galangin 270.2 426 
185.05 [14] 
11 [10] 
3-Hydroxyflavone 238.2 525 >200 [10] 
Hesperetin 302.3 >413   
Naringenin 272.2 >459 >200 [10] 
5-Hydroxyflavone 238.2 >525   
Flavone 222.1 >563 >200 [10] 
Chrysin 254.2 >492 >200 [10] 
7-Hydroxyflavone 238.2 >525   
6-Hydroxyflavone 238.2 >525   
Apigenin 270.2 >463 >200 [10] 
EC50, 50% effective concentration; MW, molecular weight. 
Because of the capacity of flavonoids to inhibit spore germination of pathogens in plants, flavonoids 
have been proposed for use against fungal pathogens in humans [15]. Several authors have reported on 
the ability of flavonoids and flavonoid derivatives to inhibit the growth of C. albicans [16,17]. In this 
work, we found strong activity of two flavonoids against Candida species: baicalein, whose MIC values 
were 5.2–21 µg/mL, and myricetin, whose MIC values were 16–64 µg/mL. These values obtained using 
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baicalein agree with those recently reported by Serpa [16] against C. albicans, C. tropicalis, and  
C. parapsilosis. Li et al. [18] evaluated the effects of myricetin on the growth of fungi, yeast, and bacteria, 
among them C. albicans, although they did not report the effects of this compound on the growth of  
C. albicans. Li et al. used Sabouraud’s dextrose broth, whereas we used RPMI-1640 medium; several 
authors have reported that the medium composition can affect susceptibility to antifungal agents [19]. 
The most interesting result in our study was that a large number of flavonoids exerted inhibitory 
activity against clinical isolates of C. glabrata, which has not been reported previously for any of these 
flavonoids. These results are particularly important considering that vaginal candidiasis in Mexico is 
caused mainly by C. glabrata. This yeast is persistent and is resistant to fluconazole, the most widely 
used antifungal drug [4]. There is limited information in the literature about the effects of polyphenolic 
compounds on the inhibition of growth of C. glabrata [20,21]. We report here that eight flavonoids had 
strong activity; two are flavones and the other six are free or glycosylated flavonols. The presence or 
absence of a sugar moiety did not seem to influence the activity against C. glabrata (e.g., compare the 
activity of myricitrin vs. myricetin, and quercetin vs. quercitrin). 
All of the flavonols and two flavones that we analyzed were active against C. glabrata, but the activity 
was markedly greater for compounds that showed two ortho–OH groups. The hydroxylation pattern on the 
B or C ring of the flavonoid may determine the degree of activity, and catechol structures may be the most 
active (e.g., compare apigenin vs. luteolin and quercetin vs. kaempferol). The exception was 3-hydroxyflavone. 
Considering that this structural requirement is similar to what has been reported for the antioxidant 
activity of flavonoids [22,23], in the next step, we wanted to study further pure compounds with an  
EC50 > 125 µg/mL, which could be regarded as indicating inactivity. Using our current results, we divided 
the flavonoids into those with high free radical-scavenging activity (EC50 < 20 µg/mL) and those with little 
or no antioxidant capacity (EC50 > 100 µg/mL). Interestingly, the compounds with greater antioxidant 
activity (EC50 < 20 µg/mL) also showed activity against C. glabrata, with only kaempferol as the exception. 
Silva described three important requirements of a flavonoid for being a good free radical scavenger: 
(1) an o-catechol B-ring group, which is regarded as the key feature; (2) a double bond in C2–C3, which 
ensures B-ring conjugation with the 4-oxo group; and (3) –OH groups at C3 and C5, which allow the 
delocalization of the 4-oxo group to both substituents [24]. The combination of these factors allows a 
greater electron delocalization. Although kaempferol lacks the first characteristic, it has the second and 
third characteristics and may function as a free radical scavenger. Most previous studies have focused 
on the catechol structure in the B ring, and little research has been done on the A ring. Marković recently 
performed structure-activity studies and demonstrated the importance of the A ring, which determines 
the antioxidant activity of baicalein [25]. Our results are consistent with these other findings. 
The presence of a third –OH group at the ortho position to the catechol structure exerts little influence 
on the antioxidant capacity of the flavonoid, as shown by the results obtained with quercetin and 
myricetin. However, this third –OH group seemed to influence the activity against C. glabrata, because the 
two compounds with greater activity (i.e., myricetin and baicalein) have a pattern of hydroxylation with three 
–OH groups on neighboring carbons (Table 3), although one is a flavone and the other a flavonol. 
Baicalein, which is obtained from Scutellaria baicalensis, has been shown in pharmacological studies 
to have antioxidant, neuroprotective, antimicrobial, and antiviral activities [26,27]. Baicalein also has 
antifungal activity, such as the ability to inhibit the growth of C. albicans, and exhibits synergism with 
fluconazole [28,29]. A recent report showed that baicalein can induce apoptosis of C. albicans [30]. 
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Another report has shown that baicalein has activity against a clinical isolate of C. krusei, which is 
fluconazole resistant, at a level that is superior to that observed against C. albicans [31]. Our report is the 
first to show an inhibitory effect of baicalein on clinical isolates of fluconazole-resistant C. glabrata and 
that its effectiveness was five times higher than that observed against C. albicans. Myricetin, the other 
flavonoid showing high activity against C. glabrata, was also 4 to 16 times more effective than against 
C. albicans. To our knowledge, no reports of the activity of this flavonoid against Candida species have 
been published. 
Interestingly, most flavonoids with activity against C. glabrata are found at high concentration  
in natural sources with broad use, such as S. baicalensis [32], Oroxylum indicum [33], berries [34],  
capers [35], and other sources. Further studies of the mechanisms of action of these flavonoids and 
products containing these compounds may indicate whether it might be possible to generate low-cost 
drugs against candidiasis caused by this organism. 
Table 3. Polyphenols structure. 
 
Polyphenols R1 R2 R3 R4 R5 R6 R7 
Flavone –H –H –H –H –H –H –H 
3-Hydroxyflavone –H –H –H –OH –H –H –H 
5-Hydroxyflavone –H –H –OH –H –H –H –H 
6-Hydroxyflavone –H –OH –H –H –H –H –H 
7-Hydroxyflavone –OH –H –H –H –H –H –H 
Chrysin –OH –H –OH –H –H –H –H 
Apigenin –OH –H –OH –H –H –OH –H 
Baicalein –OH –OH –OH –H –H –H –H 
Luteolin –OH –H –OH –H –OH –OH –H 
Galangin –OH –H –OH –OH –H –H –H 
Kaempferol –OH –H –OH –OH –H –OH –H 
Fisetin –OH –H –H –OH –OH –OH –H 
Quercetin –OH –H –OH –OH –OH –OH –H 
Myricetin –OH –H –OH –OH –OH –OH –OH 
Quercitrin –OH –H –OH –ORha –OH –OH –H 
Myricitrin –OH –H –OH –ORha –OH –OH –OH 
3. Experimental Section 
3.1. Chemicals 
Flavone, 5-hydroxyflavone, 6-hydroxyflavone, 7-hydroxyflavone, chrysin, apigenin, baicalein, luteolin, 
naringenin, hesperetin, 3-hydroxyflavone, galangin, kaempferol, quercetin, fisetin, myricetin, RPMI-1640, 
dimethylsulfoxide (DMSO), methanol, and 2,2-diphenyl,1-picrylhydrazyl (DPPH) were purchased from 
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Sigma-Aldrich (St Louis, MO, USA). Fluconazole (Diflucan) was obtained as an intravenous solution 
at 2 mg/mL from Pfizer S.A. de C. V (Toluca de Lerdo, Mexico). Myricitrin and quercitrin were isolated 
and purified from Juglans mollis cortex, and their purity was verified by thin-layer chromatography and 
High Performance Liquid Chromatography. The structures were confirmed by the 1H-NMR and 13C-NMR 
spectra [36]. The flavonoid structures are shown in Tables 3 and 4. 
Table 4. Flavanones structure. 
 
Flavanones R1 R2 R3 
Naringenin –OH –H –OH 
Hesperetin –OH –OH –OCH3 
3.2. Antifungal Activity 
Antifungal activity was evaluated using 12 clinical isolates as study models of sensitive strains of 
yeast (the isolate numbers are given in parentheses): C. parapsilosis (96), C. tropicalis (166), C. krusei 
(168), C. albicans (501, 498, 53, and ATCC 10231), and C. glabrata (507, 531, 587, 510, 493, 482). All 
clinical isolates were obtained from cultures of blood, cerebrospinal fluid, and nails, and each Candida 
species was identified through the use of API 20C AUX strips (bioMérieux, México, D.F., Mexico) and 
standard morphological methods, in the Department of Microbiology, Faculty of Medicine, Autonomous 
University of Nuevo León. Each compound was evaluated at concentrations between 0.15 and 83 µg/mL. 
The MIC values were determined by microdilution in 96-well plates using RPMI-1640 and visual 
detection following protocol M27-A3 of the Clinical and Laboratory Standards Institute [37]. All assays 
were performed in duplicate, and sterility controls and growth controls without and with fluconazole 
(Diflucan) as blank and positive controls were included. 
3.3. Free Radical Reduction: DPPH Assay 
Antioxidant activity was determined according to the method reported by Garza [38]. Solutions of 
each compound in ethanol were serially diluted with additional ethanol to concentrations in the range of 
125 to 0.5 µg/mL. The DPPH solution was prepared at a concentration of 125 µM. Each diluted compound 
or blank (500 µL) was placed individually in a test tube, and 0.5 mL of DPPH was added. The solutions 
were stirred and allowed to react in the dark for 30 min. Spectrophotometric measurement was performed 
at a wavelength of 517 nm. The reduction of DPPH was calculated from the following equation: 
% Reduction = [(Blank − Sample)/Blank] × 100 (1)
We created a linear regression curve with the percent reduction as a function of the concentration of 
each compound and calculated the concentration that effectively reduced DPPH by 50% (EC50). All 
experiments were performed in triplicate, and the mean and standard deviation were calculated in each case. 
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4. Conclusions 
We found significant antifungal activity of a number of flavonoids, especially baicalein and myricetin, 
against clinical isolates of fluconazole-resistant C. glabrata. Flavonoids displaying greater antioxidant 
activity were the most active against C. glabrata. C. albicans was less susceptible to these flavonoids. 
Acknowledgments 
This research was funded by PROMEP No. 103.5/10/6851, SEP-CONACYT 2012 grant No. 180977, 
and PAICYT-UANL No. GSA-005-09. We thank Ivonne Carrera Rodriguez and Karina Alvarez Gámez 
(Analytical Chemistry Department of the Faculty of Medicine, Autonomous University of Nuevo León), 
for their technical assistance. 
Author Contributions 
Ricardo Salazar-Aranda and Noemí Waksman de Torres conceived and designed the  
experiments; Ricardo Salazar-Aranda and Graciela Granados-Guzmán performed the experiments; 
Graciela Granados-Guzmán and Jonathan Pérez-Meseguer analyzed the data; Gloria M. González 
contributed reagents/materials/analysis tools; Ricardo Salazar-Aranda and Noemí Waksman de Torres 
wrote the paper. 
Conflicts of Interest 
The authors declare that there is no conflict of interests regarding the publication of this paper. The 
funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of 
data; in the writing of the manuscript; and in the decision to publish the results. 
References 
1. Narain, J.P. The challenge of health & environment: Profiling risks & strategic priorities for now & 
the future. Indian J. Med. Res. 2012, 136, 185–191. 
2. Egunsola, O.; Adefurin, A.; Fakis, A.; Jacqz-Aigrain, E.; Choonara, I.; Sammons, H. Safety of 
fluconazole in paediatrics: A systematic review. Eur. J. Clin. Pharmacol. 2013, 69, 1211–1221. 
3. Pfaller, M.; Neofytos, D.; Diekema, D.; Azie, N.; Meier-Kriesche, H.U.; Quan, S.P.; Horn, D. 
Epidemiology and outcomes of candidemia in 3648 patients: Data from the prospective antifungal 
therapy (PATH Alliance®) registry, 2004–2008. Diagn. Microbiol. Infect. Dis. 2012, 74, 323–331. 
4. Buitrón, R.; Araiza-Santibañez, J.; Basurto-Kuba, E.; Bonifaz-Trujillo, A. Candida glabrata: An 
emergent opportunist in vulvovaginitis. Cir. Cir. 2009, 77, 423–427. 
5. Miceli, M.H.; Díaz, J.A.; Lee, S.A. Emerging opportunistic yeast infections. Lancet Infect. Dis. 
2011, 11, 142–151. 
6. Salazar-Aranda, R.; Pérez-López, L.A.; López-Arroyo, J.; Alanís-Garza, B.A.; Waksman de Torres, N. 
Antimicrobial and antioxidant activities of plants from northeast of Mexico. Evid. Based Complement. 
Altern. Med. 2011, 2011, doi:10.1093/ecam/nep127. 
Molecules 2015, 20 17911 
 
 
7. Bhooshan, K.; Ibrahim, S. Plantpolyphenols as dietary antioxidants in human health and disease. 
Oxid. Med. Cell. Longev. 2009, 2, 270–278. 
8. De Freitas, M.G.; Hilário, F.; Vilegas, W.; Dos Santos, L.C.; Brunetti, I.L.; Sotomayor, C.E.;  
Bauab, T.M. Correlation among antioxidant, antimicrobial, hemolytic, and antiproliferative properties 
of Leiothrix spiralis leaves extract. Int. J. Mol. Sci. 2012, 13, 9260–9277. 
9. Wu, M.J.; Huang, C.L.; Lian, T.W.; Kou, M.C.; Wang, L. Antioxidant activity of Glossogyne tenuifolia. 
J. Agric. Food Chem. 2005, 53, 6305–6312. 
10. Miyuki, F.; Toshiyuki, T.; Tetsuro, I.; Asami, N.; Naomi, Y.; Ken-ichi, N.; Nobuyasu, M.; Hironori, T.; 
Motohiko, N.; Munekazu, I. Antioxidant activity of hydroxyflavonoids. J. Health Sci. 2005, 51, 
376–378. 
11. Wang, L.; Tu, Y.C.; Lian, T.W.; Hung, J.T.; Yen, J.H.; Wu, M.J. Distinctive antioxidant and 
antiinflammatory effects of flavonols. J. Agric. Food Chem. 2006, 54, 9798–9804. 
12. Jung, S.J.; Kim, D.H.; Hong, Y.H.; Lee, J.H.; Song, H.N.; Rho, Y.D.; Baek, N.I. Flavonoids  
from the flower of Rhododendron yedoense var. Poukhanense and their antioxidant activities.  
Arch. Pharm. Res. 2007, 30, 146–150. 
13. Yokomizo, A.; Moriwaki, M. Myricitrin degraded by simulated digestion inhibits oxidation of 
human low-density lipoprotein. Biosci. Biotechnol. Biochem. 2005, 69, 693–699. 
14. Laskar, R.A.; Sk, I.; Roy, N.; Begum, N.A. Antioxidant activity of Indian propolis and its chemical 
constituents. Food Chem. 2010, 122, 233–237. 
15. Harborne, J.B.; Williams, C.A. Advances in flavonoid research since 1992. Phytochemistry 2000, 
55, 481–504. 
16. Serpa, R.; França, E.J.; Furlaneto-Maia, L.; Andrade, C.G.; Diniz, A.; Furlaneto, M.C. In vitro 
antifungal activity of the flavonoid baicalein against Candida species. J. Med. Microbiol. 2012, 61, 
1704–1708. 
17. Edziri, H.; Mastouri, M.; Mahjoub, M.A.; Mighri, Z.; Mahjoub, A.; Verschaeve, L. Antibacterial, 
antifungal and cytotoxic activities of two flavonoids from Retama raetam flowers. Molecules 2012, 
17, 7284–7293. 
18. Li, X.C.; ElSohly, H.N.; Nimrod, A.C.; Clark, A.M. Two auronols from Pseudolarix amabilis.  
J. Nat. Prod. 1999, 62, 767–769. 
19. Doern, G.V.; Tubert, T.A.; Chapin, K.; Rinaldi, M.G. Effect of medium composition on results of 
macrobroth dilution antifungal susceptibility testing of yeasts. J. Clin. Microbiol. 1986, 24, 507–511. 
20. Park, B.J.; Park, J.C.; Taguchi, H.; Fukushima, K.; Hyon, S.H.; Takatori, K. Antifungal susceptibility 
of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem. Biophys. 
Res. Commun. 2006, 347, 401–405. 
21. Patel, K.D.; Scarano, F.J.; Kondo, M.; Hurta, R.A.; Neto, C.C. Proanthocyanidin-rich extracts from 
cranberry fruit (Vaccinium macrocarpon Ait.) selectively inhibit the growth of human pathogenic 
fungi Candida spp. and Cryptococcus neoformans. J. Agric. Food Chem. 2011, 59, 12864–12873. 
22. Middleton, E., Jr.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian 
cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673–751. 
23. Razzaghi-Asl, N.; Garrido, J.; Khazraei, H.; Borges, F.; Firuzi, O. Antioxidant properties of 
hydroxycinnamic acids: A review of structure-activity relationships. Curr. Med. Chem. 2013, 20, 
4436–4450. 
Molecules 2015, 20 17912 
 
 
24. Silva, M.M.; Santos, M.R.; Caroço, G.; Rocha, R.; Justino, G.; Mira, L. Structure-antioxidant 
activity relationships of flavonoids: A re-examination. Free Radic. Res. 2002, 36, 1219–1227. 
25. Marković, Z.S.; Marković, J.M.; Milenković, D.; Filipović, N. Structural and electronic features of 
baicalein and its radicals. Monatsh. Chem. 2011, 142, 145–152. 
26. Van Leyen, K.; Arai, K.; Jin, G.; Kenyon, V.; Gerstner, B.; Rosenberg, P.A.; Holman, T.R.; Lo, E.H. 
Novel lipoxygenase inhibitors as neuroprotective reagents. J. Neurosci. Res. 2008, 86, 904–909. 
27. Zandi, K.; Teoh, B.T.; Sam, S.S.; Wong, P.F.; Mustafa, M.R.; Abubakar, S. Novel antiviral activity 
of baicalein against dengue virus. BMC Complement. Altern. Med. 2012, 12, 214–222. 
28. Cao, Y.; Dai, B.; Wang, Y.; Huang, S.; Xu, Y.; Cao, Y.; Gao, P.; Zhu, Z.; Jiang, Y. In vitro activity 
of baicalein against Candida albicans biofilms. Int. J. Antimicrob. Agents. 2008, 32, 73–77. 
29. Huang, S.; Cao, Y.Y.; Dai, B.D.; Sun, X.R.; Zhu, Z.Y.; Cao, Y.B.; Wang, Y.; Gao, P.H.; Jiang, Y.Y. 
In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant 
to fluconazole. Biol. Pharm. Bull. 2008, 31, 2234–2236. 
30. Dai, B.D.; Cao, Y.Y.; Huang, S.; Xu, Y.G.; Gao, P.H.; Wang, Y.; Jiang, Y.Y. Baicalein induces 
programmed cell death in Candida albicans. J. Microbiol. Biotechnol. 2009, 19, 803–809. 
31. Kang, K.; Fong, W.P.; Tsang, P.W. Antifungal activity of baicalein against Candida krusei does 
not involve apoptosis. Mycopathologia 2010, 170, 391–396. 
32. Gasiorowski, K.; Lamer-Zarawska, E.; Leszek, J.; Parvathaneni, K.; Yendluri, B.B.;  
Błach-Olszewska, Z.; Aliev, G. Flavones from root of Scutellaria baicalensis Georgi: Drugs of the 
future in neurodegeneration? CNS Neurol. Disord. Drug Targets 2011, 10, 184–191. 
33. Wei, X.N.; Lin, B.B.; Xie, G.Y.; Li, J.W.; Qin, M.J. Chemical constituents of seeds of  
Oroxylum indicum. Zhongguo Zhong Yao Za Zhi 2013, 38, 204–207. 
34. Vuorinen, H.; Määtta, K.; Törrönen, R. Content of the flavonols myricetin, quercetin, and kaempferol 
in Finnish berry wines. J. Agric. Food Chem. 2000, 48, 2675–2680. 
35. Zhou, H.F.; Xie, C.; Jian, R.; Kang, J.; Li, Y.; Zhuang, C.L.; Yang, F.; Zhang, L.L.; Lai, L.; Wu, T.; 
et al. Biflavonoids from caper (Capparis spinosa L.) fruits and their effects in inhibiting NF-κB 
activation. J. Agric. Food Chem. 2011, 59, 3060–3065. 
36. Pérez-Meseguer, J. Isolation, Purification, and Characterization of Antioxidant Compounds and 
Immunomodulators of Juglans mollis and Turnera diffusa. Ph.D. Thesis, Faculty of Medicine, 
Autonomous University of Nuevo León, Monterrey, N.L., Mexico, 2008. 
37. Clinical and Laboratory Standards Institute (CLSI). Clinical and laboratory standards institute. 
Reference method for broth dilution antifungal susceptibility testing of yeasts. In Approved Standard, 
3rd ed.; Protocol M27-A2; CLSI: Wayne, PA, USA, 2008. 
38. Garza-Juárez, A.; de la Salazar-Cavazos, M.L.; Salazar-Aranda, R.; Pérez-Meseguer, J.;  
de Torres, N.W. Correlation between chromatographic fingerprint and antioxidant activity of 
Turnera diffusa (Damiana). Planta Med. 2011, 77, 958–963. 
Sample Availability: Samples of the compounds are not available from the authors. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
